Dr. Lal PathLabs Q3 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
1,666.20
-1.85 (-0.11%)
-1.85 (-0.11%)Volume9.56 K
Updated: Thu 21 May, 2026 | 15:29:58
NSE
1,680.80
12.20 (0.73%)
12.20 (0.73%)Volume1.77 L
Updated: Thu 21 May, 2026 | 15:40:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Dr. Lal PathLabs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 552.70 | 493.00 | 1.04% | 478.20 | 15.58% |
| Depreciation/ Amortization | 42.10 | 35.30 | 3.95% | 35.50 | 18.59% |
| Operating Income | 107.10 | 167.20 | -41.67% | 118.50 | -9.62% |
| Net Income | 90.50 | 129.20 | -39.91% | 96.70 | -6.41% |
| Other Operating Expenses Total | 121.50 | 112.70 | -3.72% | 112.60 | 7.90% |
| Net Income Before Taxes | 124.30 | 183.10 | -38.95% | 138.30 | -10.12% |
| Total Revenue | 659.80 | 660.20 | -9.69% | 596.70 | 10.57% |
| Selling/ General/ Admin Expenses Total | 230.30 | 217.70 | -3.44% | 213.10 | 8.07% |
| Diluted Normalized EPS | 6.74 | 7.74 | -25.16% | 5.79 | 16.40% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.